LT Williams Johnson

LT William Johnson serves as a key procurement lead at the Naval Medical Research Center, supporting the Department of the Navy’s mission to enhance force health protection through advanced biomedical innovation. He manages the acquisition of specialized analytical instruments and medical devices critical to field-deployable diagnostics and infectious disease surveillance. His portfolio focuses on high-precision laboratory equipment and surgical/medical instrumentation designed for austere operational environments, ensuring Navy and Marine Corps personnel have access to cutting-edge diagnostic capabilities. Johnson’s role is central to translating scientific requirements into compliant, mission-ready contracts that align with DoD acquisition regulations and technical specifications for field use. His primary contractor relationship is with REES SCIENTIFIC CORPORATION, a trusted vendor specializing in the design and manufacture of analytical laboratory systems and medical instrumentation. Johnson consistently engages this partner for complex, high-performance equipment requiring rigorous validation and customization for military medical applications. His contracting approach emphasizes technical fidelity, performance-based outcomes, and lifecycle support, fostering long-term vendor collaboration grounded in compliance and reliability rather than volume-driven procurement. Johnson’s acquisition portfolio reflects no set-aside preferences, with 100% of awards issued under full and open competition. This indicates a strategic focus on technical capability over socioeconomic categorization, prioritizing mission-critical performance and system interoperability. While small business participation is not formally incentivized, his contracting decisions remain fully compliant with FAR guidelines, ensuring transparency and fairness in all procurement actions. His primary NAICS focus areas are 334516 (Analytical Laboratory Instrument Manufacturing) and 339112 (Surgical and Medical Instrument Manufacturing), reflecting deep expertise in procuring PCR-based diagnostic platforms, point-of-care analyzers, biosensors, and sterilizable surgical tools. He specializes in acquisitions requiring FDA-cleared or DoD-validated technologies, with a strong emphasis on ruggedized, field-deployable systems that meet military environmental and operational standards.